PATH vs WGSWW · P/E 19, rev $1.61B vs rev $305.4M
Uipath Inc (PATH) versus GeneDx Holdings Corp. (WGSWW) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
GeneDx Holdings Corp. (WGSWW) common stock listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported WGSWW revenue for 2024-12-31 was $305.4M. Net income was -$52.3M. Revenue was up 50.8% from 2023-12-31 to 2024-12-31.
PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the PATH and WGSWW stock pages for the full models.
Not investment advice.